People · Operator
Named in public records as an officer, director or promoter · active 2025–2026 · Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lunair Medical, Inc. | — | Healthtech | Series A | $7.5M | $24.8M | 2025 |
| Bone Foam, Inc. | — | Other Health Care | Pre-Seed | $290K | $581K | 2026 |
Mark Christopherson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Christopherson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL LAVIOLETTE | 1 | 12 |
| David Neustaedter | 1 | 7 |
| Howard Levin | 1 | 3 |
| Michael Hurley | 1 | 1 |
| John Alexander Peterson | 1 | 1 |
| Robert Alexander Korljan | 1 | 1 |
| Peter Alexander Cole | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.